Marvell risks paying a peak-scarcity price for Lumentum if optical supply catches up by 2028-30. The proposed ~$99B deal values Lumentum at roughly 20x guided annualized revenue and 58x estimated after-tax operating income, while Lumentum, Coherent and Chinese suppliers are adding laser capacity. The DSP-and-laser combination has strategic logic, but durable scarcity economics and Nvidia's response remain uncertain. x.com 

Lumentum is a great business, but at $954 its risk/reward is not attractive. Applying 30x to fiscal 2028 non-GAAP EPS of $40 gives a 2027 price target of $1,200, about 26% upside, or roughly 15% after adjusting for execution, financial, technology and supply risks. Reaching it needs on-time manufacturing ramps, sustained pricing power and cash flow without excessive dilution. Lost pricing power plus slipping OCS or laser ramps would break the thesis; a significant dip would offer a better entry. … Show more

Lumentum's 109% year-on-year growth and sold-out capacity through 2029 make selling its AI optics exposure questionable. Bloomberg reported Marvell is in advanced talks to buy it; the appeal depends on the price, especially when holders of an $80 billion Lumentum would become holders of a $320 billion-plus Marvell growing 37%. x.com 

Applied Optoelectronics looks undervalued if its capacity converts into the modeled revenue ramp. From disclosed capacity, quarterly revenue could rise from $858M in Q1 2027 to $1.89B in Q4 and $2.14B in Q1 2028, against a $6.8B market cap. A $7.5B annualized exit rate in 2027 at 40% gross margins would make an unchanged valuation surprising. Lumentum's capacity agreements into 2030-31 suggest demand may last beyond 2027-28, but execution risk remains. x.com 

Lumentum's valuation echoes JDS Uniphase, half of which became Lumentum, because both rest on distant buildout expectations that may not materialize. If Lumentum hits estimates two years out and earnings then plateau, the valuation would be insane; only later years justify it, and JDSU also had rational forward multiples in the out years. @KairosPraxis counters that Lumentum has good contract visibility for two years, unlike JDSU's $100B value on $1B of revenue. x.com  x.com  x.com 

Lumentum's 49x free cash flow will look like an obvious bargain as very strong demand for its products turns into rapidly expanding free cash flow. The near-term fear that AI must pace the frontier is just a narrative. Unlike Applied Optoelectronics, which still burns meaningful cash and must raise capital from time to time, Lumentum is mature and no longer needs outside capital. The only question is how long the market takes to recognize it. x.com  x.com 

Astera Labs looks relatively expensive because similarly fast-growing AI infrastructure names trade at much lower multiples. Broadcom and Nvidia are at 14x, Credo at 15x and Lumentum at 18x; comparable peers look 50-80% cheaper. Astera is a great company and not necessarily expensive in absolute terms. Its roughly 2x multiple over Credo may persist, but the setup looks harder; with no valuation support, it could fall 50% if weakness continues. x.com  x.com  x.com  x.com 

The Lumentum merger makes Marvell's path toward a $1 trillion valuation look clearer if it executes well. Jensen Huang had called Marvell the next $1 trillion company. Lumentum's demand is sold for the next two to three years, though whether that gives Marvell an edge remains an open question. Marvell looks like a long-term opportunity, but the route to building a position is still unclear. x.com 

Lumentum's valuation is supported by Nvidia's co-packaged optics scale-out progressing faster than expected. Spectrum-X CPO switches are in mass production on better component yields, with shipments forecast at 15k in 4Q26 rising to 100k in 2027. CPO and NPO are seen contributing 12% and 26% of Lumentum's revenue in 2027 and 2028. Scale-up optical engine estimates were revised to 6.5m and 42m for 2027 and 2028, with full NPO adoption for the cycle retained. x.com 

Owning Lumentum's laser fab could secure Marvell's FY28 supply and hedge its DSP franchise as optical links shift to CPO. The rumored deal's strategy makes sense, but short-term pain is likely: at a 30% premium, roughly $17.5B in new debt and the rest in stock, rough math puts EPS dilution near 15%. It turns accretive only if Lumentum outgrows Marvell at today's guided rates for five or six more quarters, which looks achievable while the laser shortage lasts. x.com  x.com  x.com